Blog — HRT

Estrogen's Vital Role in Perimenopause

Publié par Behcet Bicakci le

By Dr. Sherry LaBeck of ZRT Lab Perimenopause is the transition between a woman's reproductive years and menopause, characterized by a decline in estrogen levels, which can lead to physical and emotional symptoms. Understanding the role of estrogen during this phase is essential for managing symptoms and improving the quality of life for women going through this transition. What is Perimenopause? Perimenopause typically begins in a woman's 40s, though some may experience symptoms as early as their mid-30s, which is known as premature menopause. During this phase, the ovaries produce less estrogen until menstruation stops, marking the onset of menopause....

Plus →


Perimenopause, Symptoms and Treatment

Publié par Ben White le

Perimenopause, also known as the menopausal transition, is a natural and normal part of a woman's life. It refers to the years leading up to menopause, which is defined as the point at which a woman has not had a menstrual period for 12 consecutive months. Perimenopause typically begins in a woman's 40s but can start as early as the mid-30s. During perimenopause, the body's production of estrogen and progesterone, two hormones essential to a woman's reproductive system, begins to decline. This decline can cause a range of symptoms, including hot flashes, night sweats, mood swings, sleep disturbances, vaginal dryness,...

Plus →


Trials of HRT Started in Early Menopause - Research Updates

Publié par Ben White le

One of the primary objectives of the Women's Health Initiative was to see if postmenopausal hormone replacement therapy (HRT) improved long-term risk of coronary heart disease, among other chronic diseases. However, the combined estrogen/progestin (Prempro) arm was halted in 2002, citing that the participants’ risk of cardiovascular disease outweighed any potential benefit of HRT in the prevention of colorectal cancer and bone fracture [1]. The conjugated equine estrogen (CEE)-only arm was also halted in 2004 citing no improvement in heart disease risk but an increased incidence of stroke, and no benefit in terms of fractures, although there was a reduced breast...

Plus →